How to Cite
Abstract
Juvenile idiopathic arthritis (which for practical purposes we will cite as JIA) is a systemic, inflammatory, chronic disease of unknown cause that affects patients under 18 years of age. It is considered the most frequent autoimmune and rheumatic disease in children and adolescents. JIA encompasses several different subgroups and occurs predominantly as peripheral arthritis. The spectrum of the disease manifests itself through various clinical conditions. By definition, the onset of the disease before the age of 16 and arthritis for more than 6 weeks are necessary criteria for the diagnosis of JIA. The diagnosis is clinical and the exclusion is made based on laboratory tests, with findings that support the diagnosis. Currently, with the treatments available, disease modifying medications such as methotrexate and biological therapy are first-line; Thus, it is possible to maintain adequate control of the disease and thus avoid possible complications.
Keywords
References
Muñoz, G.; Saltos, A.; Moreno, Á. Diagnóstico de artritis idiopática juvenil en el primer nivel de atención: a propósito de un caso.Revista Cubana de Reumatologia.sld.cu. 2019. http://dx.doi.org/10.5281/zenodo.2579278
Barut, K.; Adrovic, A.; Şahin, S.; Kasapçopu, Ö. Juvenile Idiopathic Arthritis. Balkan Medical Journal. 2017;34(2):90-101. https://doi.org/10.4274/balkanmedj.2017.0111
Pessler, F. Artritis idiopática juvenil (AIJ) - Pediatría - Manual MSD versión para profesionales [Internet]. [consultado 25 Marzo 2020]. Manual MSD versión para profesionales. 2018. Disponible en : https://www.msdmanuals.com/es-cr/professional/pediatr%C3%ADa/artritis-idiopática-juvenil/artritis-idiopática-juvenil-aij
Kliegman R, Stanton B, St. Geme J, Schor N, Behrman R, Nelson W. Nelson textbook of pediatrics. 21st ed. Elselvier; 2019;5173-5205.
Shenoi, S. Juvenile Idiopathic Arthritis - Changing Times, Changing Terms, Changing Treatments. Pediatrics in Review. 2017; 38(5):221-232. https://doi.org/10.1542/pir.2016-0148
Grevich, S.; Shenoi, S. Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition. Adolescent Health, Medicine and Therapeutics. 2017; Volume 8:125-135. https://doi.org/10.2147/AHMT.S109495
Pullen, L. Draft Guidelines & Recommendations for Juvenile Idiopathic Arthritis. [Internet]. [consultado 26 Marzo 2020]. The Rheumatologist. 2019. Disponible en: https://www.the-rheumatologist.org/article/updated-guidelines-recommendations-for-juvenile-idiopathic-arthritis/?singlepage=1&theme=print-friendly
Roth-Wojcicki, E. Artritis Juvenil [Internet]. [consultado 26 Marzo 2020]. Colegio Americano de Reumatología. 2019. Disponible en: https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Enfermedades-y-Condiciones/Artritis-Juvenil
Urbaneja, E.; Solís, P. Artritis idiopática juvenil. [Internet]. [Consultado 26 Marzo 2020]. Pediatría Integral. 2017.;XXI(3):170-182. Disponible en: https://www.pediatriaintegral.es/publicacion-2017-04/artritis-idiopatica-juvenil/
Martini, A. et al. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. The Journal of Rheumatology. 2018;46(2):190-197. https://doi.org/10.3899/jrheum.180168
Russo R, Katsicas M. Artritis idiopática juvenil sistémica [Internet]. [consultado 27 Marzo 2020]. 3rd ed. Buenos Aires: Autoinmunidad; 2018. Disponible en : https://www.researchgate.net/profile/Ricardo_Russo2/publication/325642818_Artritis_idiopatica_juvenil_sistemica/links/5b19ea2eaca272021cf22314/Artritis-idiopática-juvenil-sistémica.pdf?origin=publication_detail
Rusell F, Anderson C, Martin N. Juvenile idiopathic arthritis (JIA), management in children [Internet]. [consultado 27 Marzo 2020]. GG&C Paediatric Guidelines. 2019. Disponible en : https://www.clinicalguidelines.scot.nhs.uk/ggc-paediatric-guidelines/ggc-guidelines/emergency-medicine/juvenile-idiopathic-arthritis-jia-management-in-children/https://www.clinicalguidelines.scot.nhs.uk/ggc-paediatric-guidelines/ggc-guidelines/emergency-medicine/juvenile-idiopathic-arthritis-jia-management-in-children/
Giancane, G. et al. Juvenile Idiopathic Arthritis: Diagnosis and Treatment. Springer Health Rheumatology and Therapy. 2016;3(2):187-207. https://doi.org/10.1007/s40744-016-0040-4
Barral, E. et al. Metotrexato en artritis idiopática juvenil: efectos adversos y factores asociados. Anales de Pediatría. 2020; 92(3):124- 131.https://doi.org/10.1016/j.anpedi.2019.05.010
Ringold, S. et al. American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Care & Research. American College of Rheumatology. 2019; 71(6):717-734. https://doi.org/10.1002/acr.23870
Eng, S.; Aeschlimann, F.; Van Veenendaal, M.; Berard, R.; Rosenberg, A.; Morris, Q. et al. Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization. PLOS Medicine. 2019; 16(2):e1002750. https://doi.org/10.1371/journal.pmed.1002750
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Array